Abstract
Prevention and treatment of pain in preterm and term neonates became major issues in neonatal care since the landmark observations of Anand et al. on the impact of (in) adequate analgesia on mortality and morbidity after surgery in preterm neonates. Safe and effective analgesia does require thorough understanding of maturational clinical pharmacology. In the current review we summarized the available data on both pharmacokinetics and – dynamics of analgesics of various potency (potent opioids, moderate potent opioids, non-selective cyclo-oxygenase inhibitors and acetaminophen) in neonates. The available information on developmental pharmacology in neonates has extended significantly, but we have to be aware that most studies focussed on aspects of pharmacokinetics, and not yet on aspects of pharmacodynamics. The currently available information on developmental pharmacology of analgesics in neonates still needs to be further integrated in a multimodal, approach to prevent and treat pain in the neonate.
Keywords: Analgesia, neonate, developmental pharmacology
Current Drug Therapy
Title: Clinical Pharmacology of Systemic Analgesics in Neonates
Volume: 4 Issue: 3
Author(s): Karel Allegaert
Affiliation:
Keywords: Analgesia, neonate, developmental pharmacology
Abstract: Prevention and treatment of pain in preterm and term neonates became major issues in neonatal care since the landmark observations of Anand et al. on the impact of (in) adequate analgesia on mortality and morbidity after surgery in preterm neonates. Safe and effective analgesia does require thorough understanding of maturational clinical pharmacology. In the current review we summarized the available data on both pharmacokinetics and – dynamics of analgesics of various potency (potent opioids, moderate potent opioids, non-selective cyclo-oxygenase inhibitors and acetaminophen) in neonates. The available information on developmental pharmacology in neonates has extended significantly, but we have to be aware that most studies focussed on aspects of pharmacokinetics, and not yet on aspects of pharmacodynamics. The currently available information on developmental pharmacology of analgesics in neonates still needs to be further integrated in a multimodal, approach to prevent and treat pain in the neonate.
Export Options
About this article
Cite this article as:
Allegaert Karel, Clinical Pharmacology of Systemic Analgesics in Neonates, Current Drug Therapy 2009; 4 (3) . https://dx.doi.org/10.2174/157488509789055009
DOI https://dx.doi.org/10.2174/157488509789055009 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacological Interventions on Asymmetric Dimethylarginine, a Clinical Marker of Vascular Disease
Current Medicinal Chemistry Epidemiology and Etiology of Alzheimer’s disease: From Genetic to Non- Genetic Factors
Current Alzheimer Research Intravenous Antihypertensives within Cardiovascular-Based Continuity of Care
Current Vascular Pharmacology In Vitro CYP2D Inhibitory Effect and Influence on Pharmacokinetics and Pharmacodynamic Parameters of Metoprolol Succinate by Terminalia arjuna in Rats
Drug Metabolism Letters The Oxygen Therapy
Current Medicinal Chemistry Targeting the Endocannabinod System to Limit Myocardial and Cerebral Ischemic and Reperfusion Injury
Current Pharmaceutical Biotechnology Context-Dependency of Relations Between Cardiovascular Phenotypes and Genes Involved in Sodium Homeostasis: Findings from the European Project on Genes in Hypertension
Current Hypertension Reviews Colloid Update
Current Pharmaceutical Design The Role of Venous Abnormalities in Neurological Disease
Reviews on Recent Clinical Trials Intravenous Immunoglobulin as a Potential Therapy for Refractory Urticaria - A Review
Inflammation & Allergy - Drug Targets (Discontinued) Role of WNK Kinases in Blood Pressure Control
Current Hypertension Reviews The Role of IRE1 Signaling in the Central Nervous System Diseases
Current Neuropharmacology Recent Advances in Endocrine Metabolic Immune Disorders Drug Targeting: An Editorial Overview
Endocrine, Metabolic & Immune Disorders - Drug Targets Effects of Physical Exercise on Depressive Symptoms and Biomarkers in Depression
CNS & Neurological Disorders - Drug Targets Polyphenols and Neuroprotection against Ischemia and Neurodegeneration
Mini-Reviews in Medicinal Chemistry Neutrophil Function in Severe Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets Therapeutic Effects of Renal Denervation on Renal Failure
Current Neurovascular Research Empagliflozin and the Diabetic Kidney: Pathophysiological Concepts and Future Challenges
Endocrine, Metabolic & Immune Disorders - Drug Targets Spontaneous Pneumothorax
Current Respiratory Medicine Reviews Outcomes of Patients with Chronic Heart Failure and Iron Deficiency Treated with Intravenous Iron: A Meta-analysis
Cardiovascular & Hematological Disorders-Drug Targets